Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity

Systems established for active drug safety monitoring and management of drug-resistant TB should be leveraged to ensure comprehensive surveillance for active toxicity monitoring during scale-up of newer antiretroviral regimens.

Detalles Bibliográficos
Autores principales: Stevens, Lisa, Perry, Kelly E., Moide, Iakuna, Kaemala, Francil, Nankinga, Justine, Innes, Anh L., Mogaba, Ignatius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2022
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053160/
https://www.ncbi.nlm.nih.gov/pubmed/35487562
http://dx.doi.org/10.9745/GHSP-D-21-00595
_version_ 1784696937999499264
author Stevens, Lisa
Perry, Kelly E.
Moide, Iakuna
Kaemala, Francil
Nankinga, Justine
Innes, Anh L.
Mogaba, Ignatius
author_facet Stevens, Lisa
Perry, Kelly E.
Moide, Iakuna
Kaemala, Francil
Nankinga, Justine
Innes, Anh L.
Mogaba, Ignatius
author_sort Stevens, Lisa
collection PubMed
description Systems established for active drug safety monitoring and management of drug-resistant TB should be leveraged to ensure comprehensive surveillance for active toxicity monitoring during scale-up of newer antiretroviral regimens.
format Online
Article
Text
id pubmed-9053160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-90531602022-04-29 Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity Stevens, Lisa Perry, Kelly E. Moide, Iakuna Kaemala, Francil Nankinga, Justine Innes, Anh L. Mogaba, Ignatius Glob Health Sci Pract Commentaries Systems established for active drug safety monitoring and management of drug-resistant TB should be leveraged to ensure comprehensive surveillance for active toxicity monitoring during scale-up of newer antiretroviral regimens. Global Health: Science and Practice 2022-04-28 /pmc/articles/PMC9053160/ /pubmed/35487562 http://dx.doi.org/10.9745/GHSP-D-21-00595 Text en © Stevens et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit https://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-21-00595
spellingShingle Commentaries
Stevens, Lisa
Perry, Kelly E.
Moide, Iakuna
Kaemala, Francil
Nankinga, Justine
Innes, Anh L.
Mogaba, Ignatius
Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
title Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
title_full Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
title_fullStr Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
title_full_unstemmed Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
title_short Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
title_sort leveraging experience from active tb drug-safety monitoring and management for monitoring active antiretroviral toxicity
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053160/
https://www.ncbi.nlm.nih.gov/pubmed/35487562
http://dx.doi.org/10.9745/GHSP-D-21-00595
work_keys_str_mv AT stevenslisa leveragingexperiencefromactivetbdrugsafetymonitoringandmanagementformonitoringactiveantiretroviraltoxicity
AT perrykellye leveragingexperiencefromactivetbdrugsafetymonitoringandmanagementformonitoringactiveantiretroviraltoxicity
AT moideiakuna leveragingexperiencefromactivetbdrugsafetymonitoringandmanagementformonitoringactiveantiretroviraltoxicity
AT kaemalafrancil leveragingexperiencefromactivetbdrugsafetymonitoringandmanagementformonitoringactiveantiretroviraltoxicity
AT nankingajustine leveragingexperiencefromactivetbdrugsafetymonitoringandmanagementformonitoringactiveantiretroviraltoxicity
AT innesanhl leveragingexperiencefromactivetbdrugsafetymonitoringandmanagementformonitoringactiveantiretroviraltoxicity
AT mogabaignatius leveragingexperiencefromactivetbdrugsafetymonitoringandmanagementformonitoringactiveantiretroviraltoxicity

Ejemplares similares